Oncolytics Biotech Inc T.ONC

Deals are abound!!!!

[fox7mf]

Biotechs are getting bought up at what seems like a weekly rate. Many post about these acquisitions here, suggesting they have to be good news for Onc. But...how much will BP spend before they've spent enough, and will Onc have a deal when it's over? I'm confident in the science...confident in the Parsons addition.. but I continue to worry that Coffey might be asking for too much.

[Lesalpes29]

Deal for CAR-T or something else are really possible. A good buyout offer at this time, I don't see it. Patience needed!

[fox7mf]

It's interesting how you don't see a competitive buyout offer for a biotech with possibly two ph3's on the horizon, when preclinicals in similar spaces are being gobbled up in multi billion dollar deals. We'll see I guess.

[Lesalpes29]

It's the other possibilty... biding war.

[askretka]

It's interesting that Roche has 1. very good Pancreatic data with Pelareorep/ Tecentriq. -------------------------- 2. In June got first approval ever for Roche's Lunsumio is the first CD20xCD3 bispecific antibody approved anywhere. ---------------------------- 3. Roche is extending its reach in cancer cell therapy,announcingon Wednesday a new deal to develop off-the-shelf treatments with

[Kswdelux]

Exactly !!! it is all very intersting to see Roche's direction with all these areas that seem to surround Pela's ability to make all of thier directions work better. That is why I am personally thinking Roche will step up. But only time will tell.

[Buckhenry]

I have been a long term holder. I am thinking Matt wants at least 5 Billion. But he only can hold out so long. Thoughts?

[fox7mf]

I tend to think that Matt wants a bit more than $5b, and he believes the continuous positive results Pela exhibits in multiple indications proves its worth. I also believe he & the BOD brought in Jim Parsons to help facilitate a BP deal, as Matt is in over his head in this area. Parsons was a very astute add on. What the final deal will look like numbers wise, I don't know, I just hope it&

[Lesalpes29]

I would take less than 2.5B!

[canadafan]

In context of knowing zero about any in place negotiations, I can only comment on my previous & acquired knowledge. Just after the A.N. Deal & long before our existing  bracelet( Pfizer) , CAR-t , end newest GREAT panc cancer results out of Goblet ( ROche), it was discussed " they" would only consider a number starting with a B...aka $ billion . Move that forward to today

[westcoast1000]

I agree with Lesalpes. A figure of $2.5 bill is about $43 share price. $580 mil is about $10 share price. 

[Buckhenry]

The thing here is Matt has poured his life into this and I dont think he is going to sell at this time. if the revenue projections are correct they would see close to 5B in 2025. if that is even close I would not sell the company for anything less than 50B if I were him. the one issue is.... can he hold out until he gets that revenue stream. the stock price would obviously go up dramatically if

[Lesalpes29]

Don’t know but if the product prove to be effective in all studies that are going on, how can we prevent a cheap buyout. Of course, if results continue to be good the SP will follow and will be in a better shape. I’m concern about an hostile and cheap buyout.